Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
April 3, 2016 02:00 pm

Researchers Develop Cancer-Targetting Hybrid Molecule

New York researchers have developed a hybrid molecule that can target cancer cells, which they believe shows promise in the fight against breast cancer. The team created a composite nanoparticle that can transport chemotherapeutic agents, in a technique that more than doubled the uptake of an anti-inflammatory compound that inhibits cancer cell growth when directly applied to a tumor. The composite nanoparticle "can load up with these drugs, carry them to malignant cells, and unload them where they can do the most damage with the least amount of harm to the patient," according to a statement from the NYU Tandon School of Engineering, with one of the researchers summarizing it as a hybird molecule that "can carry higher payloads, enabling it to deliver more drug."

Read more of this story at Slashdot.


Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/sQvF6HGn9Fg/researchers-develop-cancer-targetting-hybrid-molecule

Share this article:    Share on Facebook
View Full Article

Slashdot

Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..

More About this Source Visit Slashdot